Non-follicular lymphoma

CD2_NONFOLLICULAR_LYMPHOMA

neoplasm of mature B-cells: A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C83 Hospital discharge: ICD-9 — 200 Hospital discharge: excluded ICD-9 — 200A Cause of death: ICD-10 — C83 Cause of death: ICD-9 — 200 Cause of death: excluded ICD-9 — 200A 2 out of 7 registries used, show all original rules.	3835
4. Check minimum number of events None	3835
5. Include endpoints None	3835
6. Filter based on genotype QC (FinnGen only)	3729

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: C81-C96
Name in latin: Lymphoma non-Hodgkin diffusum

NAME	CD2_NONFOLLICULAR_LYMPHOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C83
HD_ICD_9	200
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	200A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C83
COD_ICD_9	200
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	200A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-follicular lymphoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3729	1552	2177
Unadjusted period prevalence (%)	0.81	0.55	1.00
Median age at first event (years)	66.83	65.36	67.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3835: Matched controls
38350

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

23.9

315.9

228

101

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

71.1

313.5

170

R50.9

ICD-10 Finland

Fever, unspecified

4.1

308.4

1111

3493

ZX120

NOMESCO Finland

Intravenous

5.2

307.7

901

2132

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

65.6

307.7

400

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

177.2

307.7

354

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

58.9

307.7

759

160

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.4

307.7

622

1122

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

10.2

307.7

654

758

WW500

NOMESCO Finland

Blood transfusion

14.5

307.7

844

732

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

307.7

656

A03FA01

ATC

metoclopramide; systemic, rectal

7.8

307.7

2121

5235

M04AA01

ATC

allopurinol; systemic

8.6

307.7

1880

3840

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.7

307.7

828

1060

C82.1

ICD-10 Finland

Follicular lymphoma grade II

46.0

307.7

258

JN4BD

NOMESCO Finland

Extensive body CT

8.6

307.7

1475

2597

L03AA02

ATC

filgrastim; parenteral

42.5

307.7

1236

424

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

307.7

325

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

42.1

307.7

525

144

WW300

NOMESCO Finland

Transfer of autologic stem cells

60.9

307.7

213

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

4827.0

307.7

440

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

31.1

307.7

430

155

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

23.1

307.7

1279

814

D70.82

ICD-10 Finland

Drug-induced neutropenia

25.3

307.7

451

201

L03AA14

ATC

lipegfilgrastim; parenteral

16.6

307.7

360

238

JN4AD

NOMESCO Finland

Body CT examination

6.0

307.7

1140

2515

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

168.0

307.7

2884

680

L03AA13

ATC

pegfilgrastim; parenteral

25.1

307.7

1152

646

JN6AD

NOMESCO Finland

CT of torso and neck

39.5

307.7

642

194

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

21.7

307.7

713

399

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

307.7

371

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

307.7

424

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

41.0

307.7

299

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

307.7

512

XW000

NOMESCO Finland

Bone marrow biopsy

24.1

307.7

1283

785

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

30.0

307.7

461

174

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

164.1

307.7

549

1XC02, ,

NOMESCO Finland

75.7

307.7

382

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

52.6

307.7

1116

297

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

13.8

307.7

336

265

A04AA02

ATC

granisetron; systemic, transdermal

7.1

307.7

755

1284

PJA10

NOMESCO Finland

Exploration of lymph nodes

31.1

307.7

417

150

H02AB06

ATC

prednisolone; systemic

4.1

307.7

2682

13944

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

307.7

2176

A04AA01

ATC

ondansetron; systemic, rectal

9.1

307.7

1068

1565

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

307.7

447

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.7

307.7

1070

2946

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

21.6

305.4

230

113

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

36.9

293.6

183

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

13.2

286.5

279

226

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

12.2

277.5

284

249

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

23.1

271.3

198

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

2579.1

263.4

252

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

16.6

259.3

221

141

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

10.3

242.3

279

290

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

71.4

241.7

131

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

11.8

234.4

244

219

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

54.7

223.7

127

ZX112

NOMESCO Finland

Subcutaneous

8.6

217.8

288

358

212

Kela drug reimbursment

Gout

8.0

215.2

303

406

J05AB11

ATC

valaciclovir; oral

3.5

214.7

896

3038

H02AB02

ATC

dexamethasone; systemic

3.7

212.9

810

2584

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

12.9

206.6

203

166

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

36.0

206.0

129

WZC00

NOMESCO Finland

Treatment plan or consultation

2.8

205.8

1834

9504

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

197.4

891

3159

WW409

NOMESCO Finland

Other aferesis

57.9

190.5

107

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

6.0

190.2

359

654

N02AA05

ATC

oxycodone; systemic

2.9

188.3

1184

5067

H02AB07

ATC

prednisone; oral

3.3

186.9

894

3273

WF003

NOMESCO Finland

Adjuvant radiotherapy

6.1

182.5

334

590

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

43.1

182.4

109

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

47.4

181.2

106

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.5

179.9

308

509

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.6

174.9

453

1085

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

170.7

512

1371

L01AA02

ATC

chlorambucil; oral

30.3

169.9

112

D70.89

ICD-10 Finland

Neutropenic splenomegaly

11.3

169.6

181

168

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.3

163.8

290

495

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

156.7

2328

14752

L01CB01

ATC

etoposide; systemic

17.5

154.4

127

ZX108

NOMESCO Finland

Inhalation

16.5

151.2

128

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

381.8

148.1

148

TGC00

NOMESCO Finland

Bronchial lavation

6.3

147.1

259

439

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

23.3

140.8

102

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

30.7

137.1

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.1

137.0

170

194

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.6

135.5

269

511

A02BC02

ATC

pantoprazole; systemic

2.6

134.9

2946

21508

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

19.1

134.6

106

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

132.0

126

J01MA12

ATC

levofloxacin; systemic

2.5

130.6

1063

5049

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

43.1

127.1

YNB10

NOMESCO Finland

Collection of stem cells for transplant

45.0

126.7

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

11.6

123.9

129

115

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

119.4

114

390

Kela drug reimbursment

Ibrutinib

40.7

118.8

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.5

118.3

308

735

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.4

116.1

153

188

WF004

NOMESCO Finland

Palliative radiotherapy

5.7

115.8

221

404

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.8

114.7

379

1077

XX3DW

NOMESCO Finland

Time consuming IT work

2.8

112.9

664

2667

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

10.6

112.6

124

120

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

11.6

111.7

116

103

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.4

111.6

295

712

B72

ICPC

Hodgkin Lymphoma

564.1

111.5

110

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

110.9

304

754

Z51.5

ICD-10 Finland

Palliative care

3.0

109.9

557

2062

WW402

NOMESCO Finland

Leucoferesis

62.0

109.7

D69.5

ICD-10 Finland

Secondary thrombocytopenia

20.9

108.5

XX9CD

NOMESCO Finland

Very extensive complementary CT

284.3

108.5

110

WF002

NOMESCO Finland

Radical radiotherapy

3.4

107.0

426

1366

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

11.5

106.5

111

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

106.3

461

1558

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

+∞

104.7

100

1512

Kela drug reimbursment

Ibrutinib

37.1

99.7

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

29.2

98.9

TAB00

NOMESCO Finland

Lumbar puncture

4.1

98.1

282

724

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

97.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

47.3

95.6

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

23.9

94.9

TPX15

NOMESCO Finland

Removal of vascular injection port

14.8

90.5

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

8.4

87.3

115

141

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

86.8

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

84.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.6

84.3

209

478

A07AA02

ATC

nystatin; oral

3.2

83.0

358

1200

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

82.6

L01EL01

ATC

ibrutinib; oral

47.6

80.2

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

80.2

634

2905

WZC30

NOMESCO Finland

Teaching

2.2

79.2

785

3959

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

124.2

79.2

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

78.4

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

7.9

77.9

107

138

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

77.0

1276

7778

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

15.5

76.9

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

22.7

76.7

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.1

76.3

353

1231

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.1

76.3

339

1155

WW200

NOMESCO Finland

Immunization

4.6

75.9

185

417

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

75.2

B01AB10

ATC

tinzaparin; parenteral

2.5

74.3

523

2266

B01AB05

ATC

enoxaparin; parenteral

1.9

74.2

1412

8988

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

191.2

72.4

JN4CD

NOMESCO Finland

Very extensive body CT

3.5

71.0

258

776

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.7

70.8

135

246

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

14.1

70.8

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

701.0

70.3

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

70.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

69.4

1142

6899

J05AB01

ATC

aciclovir; systemic

2.0

69.3

912

5098

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

15.1

69.1

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

69.0

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

67.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

67.7

464

1981

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

67.7

872

4833

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

27.4

67.4

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

21.1

66.4

H02AB09

ATC

hydrocortisone; systemic

4.6

66.2

161

362

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

65.8

FM1FN

NOMESCO Finland

Heart function isotope examination

12.7

65.8

ED1AA

NOMESCO Finland

Mandibular X-ray examination

10.3

65.3

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

64.8

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

64.8

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

223.8

64.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

63.9

997

5889

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.1

63.3

181

461

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

63.1

1118

6880

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.2

62.9

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

10.5

62.4

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

8.5

61.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

15.2

61.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

61.3

563

2729

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

60.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.3

60.0

503

2346

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

10.0

58.7

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

58.5

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

74.7

58.2

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

58.1

338

1328

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

93.0

58.0

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

57.4

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

56.4

EMA10

NOMESCO Finland

Biopsy of tonsil

13.4

56.2

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.4

56.1

143

334

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

121.9

56.0

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

16.4

55.6

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

10.5

54.4

R06AE07

ATC

cetirizine; oral

1.7

53.5

1538

10793

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

52.6

1252

8331

J01MA14

ATC

moxifloxacin; systemic

2.3

51.4

436

2037

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.4

50.9

136

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

50.4

384

1712

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

134.3

49.9

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

70.9

49.2

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

49.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

48.8

883

5402

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

48.2

464

2279

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.5

47.4

116

262

1AA09, ,

NOMESCO Finland

65.8

45.2

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

6.9

44.9

101

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

44.7

113

262

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

43.2

511

2707

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.3

43.0

112

266

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.5

42.9

152

449

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

12.5

42.7

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.6

42.6

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.1

42.5

E83.50

ICD-10 Finland

Hypercalcemia

5.0

42.4

188

KFC00

NOMESCO Finland

Unilateral orchiectomy

7.5

42.4

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

422.2

42.2

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

41.7

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

41.7

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

14.9

41.7

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

40.7

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

10.3

40.4

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

6.6

40.0

C03CA01

ATC

furosemide; systemic

1.6

39.9

1402

10148

ZX131

NOMESCO Finland

Intrathecal

+∞

39.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

39.6

441

2282

ZXE00

NOMESCO Finland

One hour or less

1.6

39.4

1442

10532

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

10.9

39.1

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

38.6

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

38.6

KA1FN

NOMESCO Finland

Isotope renography

7.0

38.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

38.2

1820

14084

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

6.3

38.1

103

B02.9

ICD-10 Finland

Zoster without complication

2.3

38.1

315

1450

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

37.6

9680/3-C62.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of testis, NOS

+∞

37.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

37.1

2480

20636

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

7.3

36.4

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.8

36.0

171

GEA00

NOMESCO Finland

Mediastinoscopy

9.1

36.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.8

35.9

111

299

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

35.6

477

2629

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.1

35.4

151

500

AAA10

NOMESCO Finland

Biopsy through craniotomy

78.9

34.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

34.4

1305

9536

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.3

34.0

131

408

N05CF01

ATC

zopiclone; oral

1.6

33.7

1255

9122

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

11.4

33.6

127

Kela drug reimbursment

Transplant complication

4.3

33.5

202

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.1

33.4

228

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.6

33.3

114

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.2

33.3

132

J02AC03

ATC

voriconazole; systemic

12.9

33.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

33.0

482

2730

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

33.0

1448

10900

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

32.9

152

527

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

7.6

32.7

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.0

32.6

142

9699/3-C16.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of stomach, NOS

+∞

32.3

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

32.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

32.0

375

1972

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

72.8

31.9

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

36.7

31.5

TGD00

NOMESCO Finland

Needle biopsy of lung

6.9

31.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.6

31.4

188

747

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

31.3

L01XE27

ATC

[U] ibrutinib

39.4

31.2

V03AF03

ATC

calcium folinate; systemic

11.5

30.9

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

11.5

30.9

N02BE01

ATC

paracetamol; systemic, rectal

1.7

29.9

3302

29961

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.0

29.7

133

453

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

107.6

29.7

L01BB05

ATC

fludarabine; systemic

30.3

29.4

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

29.2

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

294.2

28.8

Z52.89

ICD-10 Finland

Donor of other organ or tissue

44.1

28.7

WX402

NOMESCO Finland

General anaesthesia

1.6

28.6

735

4865

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.7

28.5

154

581

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

11.2

28.4

J02AC01

ATC

fluconazole; systemic

1.5

28.2

1142

8385

A41.8

ICD-10 Finland

Other specified sepsis

3.2

28.1

111

351

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.4

28.0

101

302

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.9

28.0

213

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.8

27.5

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

8.6

27.5

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.9

27.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

27.4

943

6677

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

38.1

27.1

CFA20

NOMESCO Finland

Biopsy of conjunctiva

10.1

26.5

A79

ICPC

Malignancy NOS

3.5

26.5

259

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

26.1

J01DB01

ATC

cefalexin; oral

1.5

25.7

2968

26504

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

7.8

25.5

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.3

25.5

310

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

25.2

171

721

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.8

25.1

202

9680/3-C17.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of small intestine, NOS

+∞

25.0

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

9.7

25.0

JAH00

NOMESCO Finland

Laparotomy

2.7

25.0

134

504

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

24.8

146

575

OAA41

NOMESCO Finland

Health check based on individual needs

8.3

24.4

Z2446

NOMESCO Finland

Social worker

2.1

24.4

245

1216

120

Kela drug reimbursment

Hypogammaglobulinaemia

24.5

24.3

3AA13, ,

NOMESCO Finland

20.2

24.3

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

8.9

24.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

24.0

164

694

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

24.0

276

1439

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

6.4

23.9

4701

FHL

Neck lymph node removal

20.8

23.8

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

67.9

23.8

N02AX02

ATC

tramadol; systemic, rectal

1.4

23.8

1599

12836

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

241.4

23.7

9591/3-C16.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS

241.4

23.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

4.9

23.6

108

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

54.4

23.0

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

22.2

23.0

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

22.2

23.0

9680/3-C42.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of spleen

+∞

22.9

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

22.9

9679/3-C38.3

ICD-O-3

Mediastinal large B-cell lymphoma of mediastinum, NOS

+∞

22.9

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

7.7

22.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.8

22.9

112

401

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

231.3

22.6

1CX01, ,

NOMESCO Finland

19.0

22.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

22.4

1173

8973

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.9

22.4

168

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

19.6

22.1

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

+∞

21.9

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

21.9

1BC01, ,

NOMESCO Finland

+∞

21.9

R50.8

ICD-10 Finland

Other specified fever

5.6

21.8

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

18.5

21.7

B02

ICPC

Lymph gland(s) enlarged/painful

5.1

21.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

21.6

1300

10183

Z3231

NOMESCO Finland

Registered nurse

1.5

21.6

1003

7494

9591/3-C09.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS

115.7

21.6

EMB10

NOMESCO Finland

Tonsillectomy

2.6

21.3

124

486

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

21.2

127

505

C82.7

ICD-10 Finland

Other types of follicular lymphoma

50.3

21.1

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.5

21.0

Z2221

NOMESCO Finland

Medical doctor

1.5

20.9

933

6908

ENA10

NOMESCO Finland

Biopsy of pharynx

8.1

20.9

9680/3-C49.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck

+∞

20.8

Z51.0

ICD-10 Finland

Radiotherapy session

3.4

20.8

220

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.7

20.7

182

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

20.7

382

2307

JAH21

NOMESCO Finland

Staging laparoscopy

77.2

20.7

UJF32

NOMESCO Finland

Coloscopy

1.4

20.6

992

7448

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

20.6

1358

10784

R4190

NOMESCO Finland

Nutritional therapy

2.4

20.5

136

568

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

41.9

20.4

JAH01

NOMESCO Finland

Laparoscopy

2.4

20.4

143

612

ZX080

NOMESCO Finland

Image guided radiotherapy

2.8

20.3

101

365

N03AX16

ATC

[U] pregabalin

1.5

20.3

824

5988

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

20.2

107

400

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

32.7

20.2

D73.1

ICD-10 Finland

Hypersplenism

32.7

20.2

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

48.3

20.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

4.5

20.1

107

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

20.0

261

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

20.0

106

397

9699/3-C34.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lung, NOS

+∞

19.8

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

19.8

9699/3-C07.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of parotid gland

+∞

19.8

C88.4

ICD-10 Finland

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]

+∞

19.8

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

19.8

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

19.8

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

19.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

19.6

784

5673

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.8

19.6

339

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.0

19.6

296

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

19.5

232

1223

B01AB04

ATC

dalteparin; parenteral

2.0

19.4

208

1057

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

26.2

19.1

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

6.2

18.9

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

18.8

B74

ICPC

Malignant neoplasm blood other

17.2

18.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.1

18.6

122

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

23.8

18.6

C85.0

ICD-10 Finland

Lymphosarcoma

100.5

18.6

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

190.9

18.5

9699/3-C42.1

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of bone marrow

190.9

18.5

9680/3-C49.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS

190.9

18.5

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.5

1446

11754

ZX121

NOMESCO Finland

Central venous catheter

6.4

18.4

WX002

NOMESCO Finland

Sedation and analgesia

1.5

18.3

716

5154

Z31.6

ICD-10 Finland

General counselling and advice on procreation

7.5

18.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

18.2

364

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

14.4

18.1

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

17.9

130

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

52.8

17.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

17.9

1261

10072

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

7.6

17.8

J01CA04

ATC

amoxicillin; systemic

1.4

17.8

2776

25051

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

17.7

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

17.7

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

17.7

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

17.7

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

95.5

17.6

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

13.1

17.4

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

6.8

17.4

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

4.2

17.4

107

ZXD05

NOMESCO Finland

Urgent procedure

1.4

17.1

1038

8074

A05AA02

ATC

ursodeoxycholic acid; oral

3.4

17.1

177

A07AA09

ATC

vancomycin; oral

3.1

17.0

223

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.0

17.0

122

ZX114

NOMESCO Finland

Intramuscular

3.4

16.9

183

9101

FHL

Bone biopsy

17.4

16.9

TK800

NOMESCO Finland

Hemodialysis

2.6

16.9

367

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.9

16.9

127

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.7

16.7

334

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

+∞

16.7

G53.0

ICD-10 Finland

Postzoster neuralgia

4.3

16.6

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

12.7

16.6

C82

ICD-10 Finland

Follicular lymphoma

90.5

16.6

C82.0

ICD-10 Finland

Follicular lymphoma grade I

170.7

16.5

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

16.5

253

1447

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.5

16.5

162

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

16.3

164

814

L04AA06

ATC

mycophenolic acid; systemic

2.9

16.3

255

372

Kela drug reimbursment

Idelalisib

40.2

16.3

L04AD01

ATC

ciclosporin; systemic

3.0

16.3

250

R4110

NOMESCO Finland

Physiotherapy

1.4

16.3

973

7541

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

16.1

116

503

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

6.8

16.1

J35.1

ICD-10 Finland

Hypertrophy of tonsils

4.1

16.1

105

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

16.8

16.1

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

16.0

200

1071

CAA30

NOMESCO Finland

Biopsy of orbit

18.6

16.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

15.8

588

4179

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

60.3

15.8

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

5.5

15.7

L04AA01

ATC

[U] ciclosporin

3.3

15.7

182

N03AX14

ATC

levetiracetam; systemic

2.4

15.7

109

466

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

15.6

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

26.4

15.6

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

11.7

15.5

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.9

15.4

117

A06AD11

ATC

lactulose; oral

1.5

15.4

583

4154

J12.8

ICD-10 Finland

Other viral pneumonia

3.8

15.4

122

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.2

15.3

185

ELB30

NOMESCO Finland

Excision of submandibular gland

4.5

15.2

A02BC01

ATC

omeprazole; systemic

1.4

15.1

966

7552

WX882

NOMESCO Finland

High dependency care

2.3

15.1

117

524

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

15.0

204

1124

WF099

NOMESCO Finland

Other radiotherapy

4.5

14.9

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

5.8

14.9

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

5.8

14.9

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

14.9

156

787

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

14.8

107

465

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.4

14.7

104

448

9680/3-C38.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS

+∞

14.6

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

+∞

14.6

9699/3-C69.6

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of orbit, NOS

+∞

14.6

9699/3-C69.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of conjunctiva

+∞

14.6

9680/3-C49.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip

+∞

14.6

9591/3-C42.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of bone marrow

80.4

14.6

L01XX52

ATC

venetoclax; oral

11.9

14.5

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.3

14.5

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

150.6

14.5

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

10.9

14.5

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

36.2

14.4

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

14.3

303

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

5.0

14.3

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

5.0

14.3

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

5.5

14.3

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

14.3

225

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

27.3

14.3

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.5

14.2

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

14.1

197

1094

EP1AE, ,

SPAT

3.4

14.1

149

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

14.0

100

433

L01AA01

ATC

cyclophosphamide; systemic

4.7

14.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

13.9

215

1234

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

13.8

427

2915

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

53.5

13.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

13.7

216

1246

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.0

13.6

9680/3-C17.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of ileum

+∞

13.5

9680/3-C30.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasal cavity

+∞

13.5

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

13.5

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.3

13.5

153

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

13.5

277

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

140.5

13.5

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

140.5

13.5

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

13.4

159

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

13.4

222

1300

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

13.3

338

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

13.3

607

4473

399

Kela drug reimbursment

Venetoclax

10.5

13.2

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.1

13.2

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

13.2

317

2046

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

13.1

633

4710

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

4.9

13.1

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.0

12.9

194

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

12.9

594

4383

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

22.6

12.9

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

12.7

184

1034

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

12.7

240

ZXA00

NOMESCO Finland

Right side

1.3

12.7

959

7663

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.6

12.5

116

9680/3-C49.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax

+∞

12.5

1DB01, ,

NOMESCO Finland

+∞

12.5

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

12.5

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

12.5

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.2

12.5

GD6AD

NOMESCO Finland

CT of chest and neck

5.2

12.5

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

9.3

12.5

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.2

12.4

106

496

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.9

12.3

ZXC95

NOMESCO Finland

Use of surgical navigator

3.0

12.3

173

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

12.2

186

1062

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

9.0

12.2

ZXA05

NOMESCO Finland

Left side

1.3

12.2

879

6966

L01XX47

ATC

[U] idelalisib

37.7

12.2

I50.1

ICD-10 Finland

Left ventricular failure

1.7

12.2

210

1243

A02BA02

ATC

ranitidine; systemic

1.4

12.1

685

5230

WVA20

NOMESCO Finland

Medicine administration

2.3

12.1

423

C10AA07

ATC

rosuvastatin; oral

0.7

12.1

711

9078

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

12.0

694

5317

CKA10

NOMESCO Finland

Biopsy of vitreous body

10.1

12.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.7

12.0

242

1496

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.5

11.9

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.8

1141

9413

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

5.4

11.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

11.8

341

2294

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.1

11.7

157

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

4.9

11.7

D73.9

ICD-10 Finland

Disease of spleen, unspecified

30.1

11.6

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.5

11.6

275

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.1

11.6

109

529

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.2

11.6

137

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

22.9

11.6

J01FF01

ATC

clindamycin; systemic

1.3

11.5

876

6992

9699/3-C44.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of skin, NOS

+∞

11.5

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

11.5

9699/3-C08.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of submandibular gland

+∞

11.5

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.8

11.4

C81

ICD-10 Finland

Hodgkin lymphoma

120.4

11.4

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

120.4

11.4

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

11.4

845

6715

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.7

11.4

231

A06AH03

ATC

naloxegol; oral

2.6

11.4

243

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

11.3

173

989

R05

ICD-10 Finland

Cough

1.4

11.3

670

5147

WX892

NOMESCO Finland

Monitored bed care

1.6

11.3

275

1779

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

8.3

11.3

1518, ,

Kela drug reimbursment

9.6

11.2

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2.3

11.2

366

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.4

11.2

120

A03

ICPC

Fever

1.5

11.2

425

3024

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.0

11.0

114

575

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

43.4

10.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.9

332

2260

ZX100

NOMESCO Finland

Oral

2.6

10.8

237

WPA13

NOMESCO Finland

Palliative consultation

5.1

10.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

10.7

156

879

6BA02, ,

NOMESCO Finland

8.8

10.7

R59

ICD-10 Finland

Enlarged lymph nodes

28.1

10.7

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

17.8

10.7

SPAT1153

SPAT

Removal of sutures

1.3

10.7

1124

9354

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

12.9

10.6

HA1AA

NOMESCO Finland

X-ray mammography

1.6

10.6

218

1353

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

60.2

10.6

ZYC03

NOMESCO Finland

Remote contact, text-based

4.1

10.6

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

10.6

135

9680/3-C41.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints

+∞

10.4

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

10.4

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

10.4

9680/3-C49.6

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS

+∞

10.4

9680/3-C17.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of duodenum

+∞

10.4

9680/3-C48.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of retroperitoneum

+∞

10.4

C88.7

ICD-10 Finland

Other malignant immunoproliferative diseases

+∞

10.4

9689/3-C42.1

ICD-O-3

Splenic marginal zone B-cell lymphoma of bone marrow

+∞

10.4

WX704

NOMESCO Finland

Intubation

1.6

10.4

253

1637

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

5.4

10.4

H26.3

ICD-10 Finland

Drug-induced cataract

3.9

10.4

A04AD12

ATC

aprepitant; systemic

2.4

10.3

279

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.1

10.3

P01BA02

ATC

hydroxychloroquine; oral

1.6

10.3

248

1600

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.7

10.2

209

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

9.6

10.2

CBA10

NOMESCO Finland

Biopsy of eyelid

3.0

10.2

143

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

10.2

466

3426

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.2

1194

10058

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.1

10.2

138

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

10.1

133

728

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

8.4

10.0

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

4.5

10.0

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.5

10.0

259

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

40.2

10.0

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.9

9.8

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

8.1

9.8

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

26.1

9.8

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

9.5

9.7

WX199

NOMESCO Finland

Other local analgesia

1.9

9.7

122

657

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.9

9.7

158

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

7.4

9.7

Z51.88

ICD-10 Finland

Other specified medical care

2.2

9.7

351

R11

ICD-10 Finland

Nausea and vomiting

1.5

9.7

264

1754

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.3

9.7

313

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

55.1

9.6

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

4.2

9.6

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.5

9.6

262

1741

XX1AD

NOMESCO Finland

Other CT-examination

3.4

9.6

102

R53

ICD-10 Finland

Malaise and fatigue

1.3

9.5

733

5842

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

10.0

9.5

C90.0

ICD-10 Finland

Multiple myeloma

2.6

9.5

206

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.5

9.4

236

9691/3-C77.0

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of head, face and neck

100.3

9.4

3AX16, ,

NOMESCO Finland

100.3

9.4

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

9.4

9699/3-C80.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of unknown primary site

+∞

9.4

9673/3-C80.9

ICD-O-3

Mantle cell lymphoma of unknown primary site

+∞

9.4

1CA02, ,

NOMESCO Finland

+∞

9.4

9680/3-C41.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of vertebral column

+∞

9.4

D11.70

ICD-10 Finland

Gland sublingual

5.2

9.4

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.3

993

8251

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.2

9.3

338

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

4.1

9.2

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

13.7

9.2

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.1

9.2

439

B99

ICPC

Blood/lymph/spleen disease other

4.2

9.2

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

11.5

9.1

5702

FHL

Local lymph node removal (eg armpit, groin)

4.6

9.1

L57.0

ICD-10 Finland

Actinic keratosis

1.4

9.1

401

2931

S04

ICPC

Lump/swelling localized

1.5

9.0

300

2077

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.7

9.0

165

D73.0

ICD-10 Finland

Hyposplenism

36.8

9.0

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

10.0

9.0

A04AA55

ATC

palonosetron, combinations; systemic

2.0

9.0

511

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.2

9.0

336

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

4.2

8.9

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.9

8.9

105

555

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.3

8.9

RS220, ,

NOMESCO Finland

2.7

8.8

167

B03XA01

ATC

erythropoietin; parenteral

2.8

8.8

145

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.2

8.7

347

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

8.7

101

531

WZC15, ,

NOMESCO Finland

3.6

8.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

8.6

244

1636

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

4.0

8.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

8.6

492

3752

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

8.5

224

1476

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

10.0

8.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

8.5

158

958

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.2

8.4

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

90.3

8.4

9591/3-C17.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS

90.3

8.4

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

90.3

8.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

8.4

313

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

8.4

307

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

8.4

1405

12260

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

8.3

327

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

8.3

KA3CT

NOMESCO Finland

Biopsy of kidney under CT guidance

+∞

8.3

9680/3-C11.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS

+∞

8.3

9690/3-C42.1

ICD-O-3

Follicular lymphoma, NOS, of bone marrow

+∞

8.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

8.3

9680/3-C07.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of parotid gland

+∞

8.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

8.3

9680/3-C16.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of body of stomach

+∞

8.3

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

8.3

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

10.8

8.3

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

7.1

8.2

ZXC40

NOMESCO Finland

Use of ultrasound

3.5

8.2

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.6

8.2

174

B73

ICPC

Leukaemia

7.5

8.1

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

4.5

8.1

JAH20

NOMESCO Finland

Staging laparotomy

17.2

8.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

8.0

175

1105

C91.7

ICD-10 Finland

Other lymphoid leukaemia

10.0

8.0

WE100

NOMESCO Finland

Profylactic cytostatic therapy

22.1

8.0

K11.2

ICD-10 Finland

Sialoadenitis

1.9

8.0

511

ZX130

NOMESCO Finland

Epidural

6.3

8.0

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.2

7.9

288

WX720

NOMESCO Finland

Own respiration

1.7

7.9

148

900

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

7.9

116

659

XX2RW, ,

NOMESCO Finland

2.7

7.8

149

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

8.5

7.8

DAB10

NOMESCO Finland

Partial excision of auricle

3.4

7.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

7.7

154

951

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.2

7.7

5701

FHL

Local exploration of lymph nodes (includes biopsy)

15.0

7.7

B00.11

ICD-10 Finland

Herpes simplex labialis

2.6

7.7

156

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

7.7

144

875

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

7.7

260

1808

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

7.4

7.7

B04

ICPC

Blood symptom/complaint

3.3

7.6

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.9

7.6

118

Z94.1

ICD-10 Finland

Heart transplant status

6.7

7.6

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

25.0

7.6

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

7.6

193

JN4DD

NOMESCO Finland

Scout CT scan of torso

8.9

7.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.5

195

1283

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

3.8

7.5

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

7.5

113

647

9591/3-C62.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS

80.3

7.4

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

80.3

7.4

1AA01, ,

NOMESCO Finland

13.4

7.4

KA3EB

NOMESCO Finland

Antegrade pyelography

3.3

7.4

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

6.0

7.4

B37.08

ICD-10 Finland

Other candidal stomatitis

3.0

7.3

104

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.7

7.3

143

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

7.3

9680/3-C49.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen

+∞

7.3

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

7.3

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

7.3

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

9680/3-C06.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of mouth, NOS

+∞

7.3

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

7.3

3AF07, ,

NOMESCO Finland

+∞

7.3

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

7.3

9680/3-C49.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder

+∞

7.3

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

6.8

7.3

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

9.4

7.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

7.3

548

4344

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.0

7.3

380

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.2

457

A02BC05

ATC

esomeprazole; systemic

1.2

7.2

1294

11321

J01.4

ICD-10 Finland

Acute pansinusitis

3.4

7.2

ELB00

NOMESCO Finland

Excision or exploration of lesion of salivary gland

6.2

7.2

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

7.2

1945

21207

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

15.8

7.2

3AA02, ,

NOMESCO Finland

15.8

7.2

J02AC04

ATC

posaconazole; systemic

15.8

7.2

J94.0

ICD-10 Finland

Chylous effusion

15.8

7.2

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

15.8

7.2

EL3AT

NOMESCO Finland

Salivary gland biopsy with ultrasound guidance

15.8

7.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.2

1294

11325

D64.8

ICD-10 Finland

Other specified anaemias

2.1

7.2

320

J01AA02

ATC

doxycycline; systemic

1.2

7.2

2654

24862

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.7

7.2

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.4

7.2

198

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.3

7.2

223

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

30.1

7.1

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

30.1

7.1

C69.60

ICD-10 Finland

Malignant tumor in orbit without histology

30.1

7.1

J02AC05

ATC

isavuconazole; systemic

30.1

7.1

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

20.0

7.1

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

20.0

7.1

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.1

7.1

308

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

7.1

164

1053

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

4.2

7.0

SAA04

NOMESCO Finland

Special examination of mouth

1.6

7.0

145

906

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

3.5

7.0

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

3.2

7.0

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.4

7.0

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.2

6.9

239

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

6.9

264

1880

J04BA02

ATC

dapsone; oral

3.7

6.9

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

13.8

6.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.5

6.8

154

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.3

6.8

N74

ICPC

Malignant neoplasm nervous system

9.3

6.8

2301

FHL

Lumbar puncture in anesthesia or operating room

40.1

6.8

9591/3-C80.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site

40.1

6.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.7

365

2759

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

6.7

128

783

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

2.9

6.7

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

22.5

6.7

WYA00

NOMESCO Finland

Screening and health check-up

2.3

6.6

199

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.6

440

3425

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

6.6

393

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

6.6

133

825

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

12.3

6.6

L04AD02

ATC

tacrolimus; systemic

2.8

6.6

111

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.5

6.6

Z31.4

ICD-10 Finland

Procreative investigation and testing

2.7

6.5

117

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.1

6.5

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

6.2

6.5

1XX08, ,

NOMESCO Finland

70.0

6.4

C779, 9715, 3

ICD-O-3

70.0

6.4

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.2

6.4

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

3.2

6.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.7

6.4

110

655

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.4

122

747

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

14.3

6.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.3

556

4491

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

5.9

6.3

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

11.0

6.3

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.0

6.3

303

C10AA01

ATC

simvastatin; oral

0.8

6.3

1305

14636

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

9.3

6.3

Z31.8

ICD-10 Finland

Other procreative management

18.0

6.3

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.2

1AD01, ,

NOMESCO Finland

+∞

6.2

C85

ICD-10 Finland

Other and unspecified types of non-Hodgkin lymphoma

+∞

6.2

9680/3-C62.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of descended testis

+∞

6.2

9680/3-C67.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bladder, NOS

+∞

6.2

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.2

9680/3-C44.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of skin, NOS

+∞

6.2

9591/3-C06.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of mouth, NOS

+∞

6.2

AAF35

NOMESCO Finland

Implantation of reservoir for intraventricular therapy

+∞

6.2

9591/3-C69.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS

+∞

6.2

PJ023

NOMESCO Finland

Adjuvant radiotherapy of mediastinal lymphnodes

+∞

6.2

C69.09

ICD-10 Finland

Malignant tumor in conjunctival other or unspecified histology

+∞

6.2

L04AX01

ATC

azathioprine; systemic

1.7

6.2

114

691

9109

FHL

Other measure in this category

7.0

6.2

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

3.7

6.2

XF602

NOMESCO Finland

Bloodpressure monitoring

2.3

6.2

193

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.5

6.2

144

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

6.2

143

919

PJD99

NOMESCO Finland

Excision of other lymph nodes

6.3

6.2

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.1

6.1

272

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

5.7

6.1

D73.5

ICD-10 Finland

Infarction of spleen

7.7

6.1

6753

FHL

Transabdominal splenectomy

7.7

6.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

2.0

6.1

327

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.4

6.1

157

A04AA03

ATC

tropisetron; systemic

4.1

6.1

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.1

6.1

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

3.8

6.1

H05.9

ICD-10 Finland

Disorder of orbit, unspecified

12.5

6.1

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

8.6

6.0

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

6.0

168

1125

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.1

6.0

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.1

6.0

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.8

6.0

435

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

10.0

6.0

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

10.0

6.0

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.3

6.0

189

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.6

6.0

116

713

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021440) Promyelocytes/100 leukocytes in Blood

952

2628

4.49

316.01

6.3

4.0

0.20

0.10

4.57

683

826

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

501

774

7.30

315.99

2.3

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2654

14536

3.68

308.60

8.6

4.9

33.84

34.92

g/l

17.53

2567

13489

(3006504) Eosinophils/100 leukocytes in Blood

2924

14650

5.19

307.65

11.1

6.0

2.62

2.87

6.76

2851

13616

(3023520) Reticulocytes [#/volume] in Blood

1108

3168

4.51

307.65

3.8

2.5

69.59

69.46

e9/l

0.03

931

2405

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3000

17052

4.49

307.65

15.4

6.3

10.75

12.08

umol/l

5.88

2960

16185

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

224

28.95

307.65

2.4

2.0

35.82

24.77

7.57

206

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1792

2897

10.73

307.65

1.5

—

(3010503) CD19 cells [#/volume] in Blood

395

149

29.44

307.65

2.8

2.0

0.22

0.17

e9/l

0.23

389

141

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

362

159

25.04

307.65

3.0

2.0

0.23

0.22

e9/l

0.12

311

136

(3027945) Reticulocytes/100 erythrocytes in Blood

1310

4189

4.23

307.65

3.8

2.5

1.79

1.78

0.10

1234

3681

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

365

178

22.56

307.65

3.2

1.9

456.62

693.45

e6/l

3.55

350

170

(3011412) CD3 cells [#/volume] in Blood

610

228

31.63

307.65

2.7

2.0

1.07

1.12

e9/l

0.34

556

199

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

573

452

14.73

307.65

2.6

4545.66

1130.32

u/ml

1.09

(3028026) IgM [Mass/volume] in Serum or Plasma

920

1776

6.50

307.65

3.2

1.8

1.65

1.28

g/l

1.88

868

1601

(1175426) CD3 cells/100 lymphocytes in Blood

505

173

33.47

307.65

2.3

1.9

73.06

69.64

1.52

484

160

(3006245) CD3-CD19+ cells/100 cells in Blood

223

29.17

307.65

2.4

2.0

11.62

12.32

0.12

195

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

492

161

34.91

307.65

2.3

1.9

—

(3019069) Monocytes/100 leukocytes in Blood

2936

14718

5.24

307.65

11.7

6.3

9.61

8.87

21.13

2860

13701

(4035726) Immunohistochemistry procedure

1470

2872

7.68

307.65

1.7

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

501

167

34.36

307.65

2.3

1.9

16.09

15.87

0.09

484

160

(3045142) Bone marrow Pathology biopsy report

814

343

29.86

307.65

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1617

1641

16.31

307.65

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

716

163

53.78

307.65

1.3

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3134

18170

4.97

307.65

25.5

8.7

3.56

4.25

e9/l

60.69

2911

15751

(3026493) Urate [Moles/volume] in Serum or Plasma

2350

8719

5.38

307.65

6.1

2.8

773.98

5736.11

umol/l

16.26

2278

7470

(3006315) Basophils [#/volume] in Blood

3036

15620

5.53

307.65

10.3

5.7

0.04

e9/l

11.88

2761

13364

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2510

4000

16.27

307.65

8.1

4.0

282.64

240.14

u/l

8.20

2452

3768

(40768795) Lymph node Pathology biopsy report

853

231

47.20

307.65

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

806

581

17.30

307.65

1.7

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

284

34.77

307.65

2.1

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1739

2667

11.10

307.65

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

343

150

25.01

307.65

3.8

2.3

33.10

41.36

4.29

246

(3022096) Basophils/100 leukocytes in Blood

2893

14240

5.20

307.65

10.8

6.0

0.68

0.67

0.48

2818

13232

(3019198) Lymphocytes [#/volume] in Blood

3046

15953

5.42

307.65

10.5

5.8

1.86

1.90

e9/l

0.29

2810

13949

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

375

168

24.63

307.65

2.9

2.0

571.72

493.30

e6/l

0.59

310

138

(3001604) Monocytes [#/volume] in Blood

3035

15573

5.55

307.65

10.3

5.7

0.61

e9/l

0.04

2757

13316

(3002030) Lymphocytes/100 leukocytes in Blood

2942

15020

5.12

307.65

11.4

6.1

27.09

26.65

0.96

2869

14010

(3002179) Metamyelocytes/100 leukocytes in Blood

944

2505

4.67

307.65

6.0

3.8

0.79

0.70

0.75

665

821

(3017181) Myelocytes/100 leukocytes in Blood

1072

2756

5.01

307.65

6.2

4.0

1.16

0.94

1.86

804

954

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

481

540

10.04

307.65

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

259

39.61

307.65

2.1

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

430

471

10.16

307.65

1.4

115.48

121.34

u/ml

0.21

111

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

653

573

13.53

307.65

4.9

5.3

2600.36

753.06

iu/ml

0.42

105

(3013115) Eosinophils [#/volume] in Blood

3062

16128

5.46

307.65

11.2

5.9

0.17

0.20

e9/l

23.92

2803

13979

(3005719) IgG [Mass/volume] in Serum or Plasma

1281

2234

8.11

307.65

4.2

2.7

8.76

10.70

g/l

28.62

1232

2018

(40760892) CBC W Ordered Manual Differential panel - Blood

3013

14667

5.92

307.65

12.9

6.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

345

417.54

307.65

8.5

18.9

0.36

0.49

umol/l

—

336

(3018010) Neutrophils/100 leukocytes in Blood

2897

14808

4.91

307.65

10.4

5.9

56.32

58.05

8.86

2822

13798

(46235355) HIV 1 and 2 tests - Meaningful Use set

1868

3434

9.66

307.65

1.5

1.6

—

(40765096) Chromosome analysis panel by Banding

268

33.82

307.65

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

503

806

7.03

306.34

2.3

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1468

5593

3.63

306.29

7.1

3.2

0.81

mmol/l

2.12

1418

5221

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

513

855

6.77

300.71

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

417

574

8.03

290.94

4.8

3.4

1.71

1.70

0.01

398

500

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

416

599

7.67

278.77

2.3

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

872

2540

4.15

265.62

2.3

2.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

281

260

11.58

264.89

1.7

1.8

4.06

4.57

mg/l

0.83

268

249

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

270

254

11.36

251.55

1.6

1.5

—

(3025159) Blasts/100 leukocytes in Blood

826

2481

3.97

239.11

6.3

4.1

0.16

0.26

0.34

544

686

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

355

515

7.49

235.51

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

154

30.81

234.42

2.4

1.8

635.28

217.73

e6/l

0.51

(3032352) Blasts [#/volume] in Cerebral spinal fluid

129

63.53

233.54

1.8

2.5

—

(3023368) Bacteria identified in Blood by Culture

1928

9851

2.92

228.74

8.1

4.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1177

4596

3.25

225.54

7.1

6.0

1.05

1.04

mmol/l

0.61

1142

4256

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

346

524

7.16

220.46

2.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

346

524

7.16

220.46

2.2

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2702

16858

3.04

215.12

12.5

7.0

1.22

1.21

mmol/l

8.93

2295

14291

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

355

570

6.76

213.95

1.9

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

391

701

6.10

211.08

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

892

3059

3.50

209.50

2.7

2.6

64.24

66.16

g/l

8.18

847

2764

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

322

479

7.25

208.37

1.3

1.2

283.51

270.21

u/ml

0.24

196

288

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2498

15354

2.80

196.75

10.8

6.2

1.22

1.21

mmol/l

6.60

2414

13927

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

304

463

7.05

192.25

1.8

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

306

486

6.76

185.90

1.9

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1286

5804

2.83

184.57

2.9

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

265

370

7.62

181.17

5.3

4.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

255

344

7.87

179.62

2.3

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

246

319

8.17

179.20

2.3

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

219

247

9.34

178.43

1.3

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

18.08

176.42

3.8

2.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

93.19

173.99

1.1

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

734

2507

3.38

170.68

2.3

1.6

—

(3018418) pH of Serum or Plasma

1810

9972

2.54

170.26

8.4

4.1

7.40

1.62

445

1912

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

24.47

170.21

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

480

1235

4.30

168.76

2.3

2.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

181

170

11.12

168.21

4.3

3.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

262

392

7.10

168.13

1.9

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

279

457

6.51

164.20

1.9

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1935

11150

2.48

163.08

7.2

3.4

2.35

mmol/l

0.43

1812

9688

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

292

512

6.09

160.45

2.0

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

203

243

8.76

157.70

2.6

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1148

5249

2.69

156.60

2.5

1.5

2.04

2.65

g/l

13.07

936

3071

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

197

234

8.82

153.96

1.3

1.2

—

(3000012) Reticulocyte production index

295

544

5.79

153.69

2.6

2.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

240

360

7.04

153.48

4.8

3.5

53.89

56.97

1.05

223

297

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

128

16.31

150.25

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1279

6309

2.54

147.83

5.1

3.1

2.47

2.46

mmol/l

4.55

1236

5515

(3037756) Immunofixation for Serum or Plasma

352

796

4.77

145.21

1.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

938

4024

2.76

143.49

2.6

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

940

4038

2.76

143.41

2.5

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2297

14901

2.35

140.10

4.4

2.7

—

(3021589) Normoblasts [#/volume] in Blood

2169

13775

2.32

138.47

18.9

10.2

0.00

e9/l

0.25

1844

11227

(40758292) HTLV I+II Ab panel - Serum

24.85

137.41

1.5

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3241

24764

2.99

136.16

19.9

7.7

83.78

79.91

u/l

4.27

3180

23289

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

225

362

6.54

134.44

1.8

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

225

362

6.54

134.44

1.8

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3087

23105

2.72

133.16

7.1

4.2

16.87

13.37

mm/h

20.65

2974

21212

(3044640) Blood type and Crossmatch panel - Blood

1747

10307

2.28

130.69

4.5

2.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

126

101

12.87

129.45

1.9

4399.37

34170.93

u/ml

0.44

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

328

771

4.56

128.63

1.3

1.2

—

(21494434) Karyotype in Bone marrow

205

334

6.43

120.87

1.2

—

(40758558) Short blood count panel - Blood

1432

7993

2.26

120.02

18.9

6.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

323

803

4.30

117.64

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

188

288

6.81

117.60

2.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

188

288

6.81

117.60

2.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

188

288

6.81

117.60

2.6

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

1434

3.39

111.75

2.5

7.23

7.40

g/l

1.17

423

1291

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

466

1544

3.30

111.20

2.7

1.9

2.60

2.62

ug/l

0.01

433

1358

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

445

1433

3.38

111.20

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

444

1431

3.38

110.78

2.5

3.67

3.70

g/l

0.09

423

1291

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

144

174

8.56

110.77

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2384

16593

2.15

110.52

16.7

18.0

1.24

1.34

inr

6.43

672

4721

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

398

1201

3.58

110.03

2.7

3.5

39.63

65.41

mg/l

1.24

322

977

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

399

1217

3.54

108.46

2.6

1.37

1.06

g/l

0.65

351

1047

(3034860) Kappa light chains.free [Mass/volume] in Serum

396

1203

3.56

108.31

2.7

3.5

61.10

56.03

mg/l

0.26

323

975

(3037692) Legionella sp identified in Specimen by Organism specific culture

119

10.29

105.61

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1382

7921

2.16

105.45

4.2

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

384

1171

3.53

104.30

2.7

3.5

7.18

2.87

ratio

0.35

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

1327

3.38

103.98

2.6

2.5

3.16

2.96

g/l

2.95

392

1187

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

411

1350

3.29

99.06

2.5

9.53

10.24

g/l

2.00

388

1197

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

20.11

97.60

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

125

9.54

97.47

3.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

115

123

9.61

97.17

3.1

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

115

123

9.61

97.17

3.1

1.8

—

(3042936) Bacteria identified in Isolate by Culture

947

4802

2.29

96.49

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1039

5500

2.22

95.18

3.1

2.1

29.56

29.99

1.38

1011

5334

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

350

1068

3.51

94.72

2.6

2.4

0.06

0.03

g/l

0.35

336

973

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

278

737

3.99

92.41

1.9

1.3

627.31

545.43

mg/l

1.52

270

690

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

231

6.62

90.80

2.1

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1386

8317

2.04

90.53

5.9

4.1

85.46

85.99

0.35

1356

8134

(40768804) Tissue Pathology biopsy report

1880

12571

1.97

89.93

2.6

2.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

137

200

7.07

89.49

2.2

1.5

—

(3042631) Mycobacterium sp identified in Specimen

221

509

4.55

88.42

2.1

2.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

252

642

4.13

88.41

2.0

1.4

22.86

25.26

e6/l

0.06

215

497

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

252

642

4.13

88.41

2.0

1.5

8258.03

822.73

e6/l

0.46

222

522

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

136

201

6.98

87.82

2.2

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

163

292

5.79

87.06

2.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

122

164

7.65

85.75

3.1

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

122

164

7.65

85.75

3.1

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

305

909

3.56

85.38

2.8

3.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

319

982

3.45

84.94

2.7

2.4

0.00

g/l

-0.00

309

907

(3016650) Hepatitis A virus Ab [Presence] in Serum

198

432

4.78

84.64

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

459

1751

2.84

84.64

2.1

1.7

1.57

1.54

g/l

0.24

385

1505

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

321

999

3.42

83.99

2.7

2.4

0.00

g/l

0.07

309

909

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

332

1060

3.33

83.38

1.7

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

342

1114

3.27

83.14

2.6

2.3

36.50

37.53

g/l

2.11

319

972

(3044290) Cell count panel - Cerebral spinal fluid

232

582

4.18

83.03

1.9

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2579

19546

1.98

81.71

7.9

4.9

6.68

6.85

mmol/l

4.38

2512

18406

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

297

916

3.43

78.72

3.3

2.5

3.74

3.56

g/l

1.00

288

870

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

734

3652

2.25

76.30

4.6

2.8

8.29

9.19

umol/l

0.53

662

3208

(3019832) Treponema pallidum Ab [Presence] in Serum

351

1228

3.05

75.41

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

237

652

3.81

74.54

1.9

1.3

3.68

3.86

mmol/l

1.40

225

605

(3008536) Aspergillus sp Ab [Presence] in Serum

11.75

73.21

2.4

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

160

331

5.00

72.79

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

7.79

70.97

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1280

7990

1.90

70.65

1.6

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

16.40

65.05

1.4

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

186

474

4.07

65.03

5.9

6.6

11.13

12.07

mg/l

2.16

171

443

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

19.13

64.93

1.8

2.4

1.52

1.19

mg/l

0.20

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

16.58

64.23

1.1

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

186

486

3.97

62.82

1.3

124.07

212.22

miu/ml

1.82

186

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1582

10834

1.78

62.80

3.7

3.1

1819.53

1605.58

ng/l

1.13

1453

9390

(3030467) Casts [#/volume] in Urine by Automated count

1427

9480

1.80

62.79

3.8

3.3

0.48

0.47

e6/l

0.04

1129

7319

(3002582) Erythrocytes [#/volume] in Urine

1530

10386

1.79

62.51

3.9

3.4

34.72

78.47

e6/l

4.11

1221

8098

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

845

4757

2.00

62.10

2.5

2.7

23.62

22.37

1.25

754

4049

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

180

6.14

62.07

1.7

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

212

613

3.60

61.85

6.7

3.4

56.61

57.78

0.52

212

613

(36304419) Bacteria [Presence] in Urine

1380

9109

1.80

61.81

3.7

3.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

176

450

4.05

61.24

1.1

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2639

21034

1.82

61.16

5.6

4.8

1364.27

1590.14

e6/l

0.08

336

(3028433) Virus identified in Specimen by Culture

100

8.25

61.12

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

107

180

6.09

60.92

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

346

4.47

59.75

3.5

2.8

—

(3018095) Leukocytes [#/volume] in Urine

1673

11763

1.75

59.69

4.5

3.9

140.32

115.17

e6/l

0.24

1275

8607

(3004789) Transferrin [Mass/volume] in Serum or Plasma

872

5029

1.95

59.43

2.4

2.6

2.15

2.28

g/l

7.99

822

4660

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

10.83

59.28

1.7

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

695

3712

2.07

58.80

2.3

4.1

9.90

20.74

ug/l

1.42

488

3092

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

241

782

3.22

58.58

1.9

1.8

11.54

11.78

mg/l

0.15

230

713

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

283

1011

2.94

58.24

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

913

5411

1.90

57.01

2.5

2.6

12.80

12.56

umol/l

0.34

866

5049

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

455

2077

2.35

56.85

1.8

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1286

8586

1.75

53.61

2.2

2.3

3.31

3.02

mg/l

3.02

1112

7295

(3000991) Gas panel - Venous blood

577

3004

2.08

51.78

8.1

8.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

102

196

5.32

50.44

2.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

660

3698

1.95

47.89

1.7

1.4

—

(3002032) Base excess in Venous blood by calculation

612

3358

1.98

47.14

5.7

3.8

1.95

2.01

mmol/l

0.14

528

2818

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

315

1333

2.49

46.25

3.4

3.0

0.36

0.34

u/ml

0.46

201

760

(3016018) Differential panel - Cerebral spinal fluid

123

299

4.22

45.78

1.9

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

9.76

45.69

2.2

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

111

251

4.52

45.33

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

607

3368

1.95

45.11

5.8

3.8

5.69

5.84

kpa

3.31

596

3258

(3012544) pH of Venous blood

623

3491

1.94

44.95

5.7

3.8

7.40

7.37

—

(3000850) Epithelial cells [#/volume] in Urine

1098

7312

1.70

44.51

3.1

2.7

3.88

4.80

e6/l

3.04

1019

6561

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

118

287

4.21

43.89

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

529

2825

2.01

43.79

10.3

4.0

1.23

1.22

mmol/l

1.28

517

2485

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

302

1293

2.45

43.18

1.9

1.8

42.63

38.38

u/l

2.38

268

1109

(3009343) pH of Capillary blood

453

2313

2.09

42.33

4.6

3.8

7.44

7.41

3.16

290

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

457

2344

2.08

42.18

4.6

3.8

5.02

5.15

kpa

2.94

446

2219

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.31

41.94

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.23

41.93

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

439

2228

2.10

41.66

4.6

3.7

2.30

1.83

mmol/l

2.02

365

1618

(3020779) Urea [Moles/volume] in Serum or Plasma

592

3341

1.91

41.56

7.9

7.3

10.33

10.48

mmol/l

0.19

577

3170

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1656

12391

1.59

41.41

3.2

2.9

391.11

153.89

ug/l

20.06

1541

11286

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.28

41.06

1.8

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

7.88

40.85

1.2

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1410

10250

1.59

39.26

2.9

2.6

55.11

67.76

u/l

0.92

1313

9444

(3037467) Urinalysis macro (dipstick) panel - Urine

2600

21771

1.60

38.86

5.4

4.5

—

(3025941) Bacteria identified in Stool by Culture

332

1558

2.24

38.33

1.4

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

110

283

3.97

37.94

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

291

1299

2.34

37.80

2.0

3.3

195.42

4138.38

u/ml

1.14

235

1113

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

892

5840

1.69

37.49

3.2

2.9

1.02

1.13

e6/l

0.42

517

3410

(3026782) Osmolality of Urine

1031

7009

1.64

37.45

3.3

3.0

534.14

547.37

mosm/kgh2o

1.33

932

6017

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.45

36.88

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

193

716

2.79

36.87

1.2

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

843

5491

1.69

35.92

3.3

3.1

1.69

1.96

e6/l

0.49

472

3083

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.15

35.58

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

192

725

2.74

35.45

2.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

415

2192

2.00

35.04

2.1

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1001

6849

1.62

35.04

4.1

4.0

332.65

546.39

ng/l

0.47

866

5760

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

987

6736

1.63

34.88

2.2

1.7

1.98

1.40

mg/l

2.23

798

5248

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

136

5.22

34.23

3.3

5.8

39.60

58.27

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

184

4.53

33.85

2.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

309

1481

2.18

33.76

3.3

1.9

—

(3026008) Bacteria identified in Urine by Culture

1379

10233

1.54

33.73

3.6

3.3

—

(3009871) Measles virus Ab [Titer] in Serum

7.29

33.47

1.9

1.5

—

(3017732) Neutrophils [#/volume] in Blood

391

2055

2.01

33.42

3.2

3.3

6.16

5.75

e9/l

0.14

308

1594

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1642

12678

1.52

33.24

2.4

2.2

78.37

78.52

nmol/l

0.08

1530

11170

(3036481) Cortisol [Moles/volume] in Serum or Plasma

490

2792

1.87

32.90

2.1

2.3

372.28

371.06

nmol/l

0.05

470

2542

(3022313) Gas panel - Capillary blood

335

1674

2.10

32.85

5.1

3.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

542

3189

1.81

32.81

7.3

6.9

1.53

1.36

mmol/l

1.78

530

3106

(3025468) Yersinia sp identified in Specimen by Organism specific culture

130

419

3.18

31.89

2.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

130

420

3.17

31.77

2.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

130

422

3.15

31.52

2.6

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1672

13056

1.50

31.49

4.6

4.0

39.75

88.34

ng/l

0.82

1407

9853

(3024522) Salmonella sp identified in Specimen by Organism specific culture

130

425

3.13

31.15

2.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

335

1709

2.05

31.03

6.9

4.1

24.52

24.21

mmol/l

0.95

330

1667

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

207

867

2.47

30.92

6.3

3.5

1.52

1.65

mg/l

1.34

192

780

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

129

422

3.13

30.87

2.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

130

429

3.10

30.66

2.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

108

319

3.45

30.49

1.3

2.1

1686.87

2494.62

u/l

0.19

127

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

203

857

2.45

29.80

1.5

1.6

1.23

11.62

iu/ml

0.79

185

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

117

369

3.24

29.77

1.4

1.3

351.44

322.70

u/l

0.20

106

352

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

175

4.35

29.50

2.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

175

4.35

29.50

2.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

151

561

2.76

28.77

1.7

2.6

—

(3002256) Pathology report gross observation

659

4241

1.67

28.69

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

532

3235

1.75

28.52

2.2

0.19

0.21

g/l

4.50

493

3014

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

237

3.78

28.52

2.1

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3349

30609

1.74

28.26

38.6

16.2

24.85

26.26

mg/l

1.78

3119

24718

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1312

9929

1.49

27.87

6.3

3.2

35.98

38.09

u/l

0.40

1255

9399

(3003434) Protein [Mass/volume] in Pleural fluid

148

554

2.74

27.80

1.7

1.5

31.40

31.79

g/l

0.15

140

499

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

284

1420

2.08

27.72

5.5

4.1

25.62

24.77

mmol/l

4.63

270

1306

(3019225) pH of Specimen

562

3497

1.71

27.69

7.6

4.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

286

3.45

27.48

1.4

6.00

6.76

g/l

0.80

200

(3024139) IgG subclass 3 [Mass/volume] in Serum

286

3.45

27.48

1.4

0.31

0.40

g/l

1.87

200

(3028192) IgG subclass 2 [Mass/volume] in Serum

286

3.45

27.48

1.4

2.14

2.97

g/l

4.10

199

(3007853) Bacteria identified in Skin by Aerobe culture

602

3825

1.68

27.41

1.9

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

574

3603

1.70

27.36

6.0

3.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

235

3.72

27.30

2.1

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

275

1370

2.09

27.09

2.4

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

130

468

2.84

26.30

1.1

1.2

—

(4062490) Immunoglobulin typing, IgG

288

3.36

25.79

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.53

25.75

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

128

463

2.83

25.67

1.5

1.6

0.50

0.87

g/l

4.49

353

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.81

25.37

1.3

1.2

19.67

23.91

0.13

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

133

498

2.73

24.99

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

138

4.48

24.98

1.5

1.2

63.83

65.13

0.03

(3023410) Appearance of Cerebral spinal fluid

287

3.30

24.55

2.5

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

165

710

2.38

23.24

1.4

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

476

2977

1.68

22.74

2.4

37.90

54.18

u/l

0.50

406

2534

(40768806) Pleura Pathology biopsy report

117

432

2.76

22.60

1.6

—

(3012441) Differential panel - Pleural fluid

116

428

2.76

22.44

1.7

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

128

512

2.55

21.12

1.2

1.1

—

(3036489) Thrombin time

229

1173

2.01

20.88

3.1

2.0

22.76

21.59

1.29

213

1064

(3001686) Cold agglutinin [Titer] in Serum or Plasma

5.92

20.87

1.6

1.3

39.88

144.25

titre

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

180

852

2.17

20.24

3.8

2.5

224.20

200.34

2.39

171

816

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

291

3.04

20.14

1.3

31.12

11.93

u/l

1.29

266

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

171

812

2.16

19.08

1.7

1.5

0.22

0.24

g/l

1.72

155

772

(3048879) Bone marrow aspiration report

112

4.33

18.96

1.9

1.5

—

(3003396) Base excess in Arterial blood by calculation

615

4263

1.53

18.88

8.9

7.1

1.43

1.12

mmol/l

1.11

487

3363

(3024471) HLA-A [Type]

4.66

18.66

1.0

—

(40768797) Stomach Pathology biopsy report

634

4434

1.51

18.65

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

174

841

2.12

18.56

1.7

1.5

1.10

1.17

g/l

1.98

167

797

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

162

763

2.17

18.46

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

162

763

2.17

18.46

1.5

1.3

—

(3016502) Oxygen saturation in Arterial blood

564

3857

1.54

18.39

9.5

7.4

96.00

95.43

1.88

541

3713

(3023199) Leukocytes [#/volume] in Pleural fluid

118

488

2.46

18.19

1.6

1.5

1981.90

1771.47

e6/l

0.25

351

(3027801) Oxygen [Partial pressure] in Arterial blood

611

4269

1.51

18.00

8.9

7.1

12.33

12.09

kpa

0.53

584

4065

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

611

4270

1.51

17.98

8.9

7.1

4.98

5.10

kpa

2.60

579

4065

(3024354) Oxygen [Partial pressure] in Venous blood

429

2771

1.62

17.87

5.5

3.2

4.71

4.56

kpa

0.65

417

2673

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

22.87

17.72

1.7

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

446

2.51

17.69

1.5

1.4

23883.47

77921.00

e6/l

1.77

258

(3035350) Ketones [Presence] in Urine by Test strip

1806

15267

1.35

17.65

4.3

3.8

0.00

estimate

1.79

457

3099

(3021960) Folate [Moles/volume] in Serum or Plasma

1059

8240

1.39

17.51

1.6

19.63

20.25

nmol/l

0.64

924

6957

(3024932) HLA-DR beta [Type]

4.59

17.49

1.4

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

383

2.60

17.01

1.5

1.4

6.13

6.48

mmol/l

0.62

358

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

223

3.13

16.99

1.4

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

123

3.94

16.79

1.2

1.1

2001.00

419.03

ng/l

0.88

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2179

19044

1.33

16.49

4.0

3.2

62.17

55.33

u/l

1.90

2032

17437

(1616796) Gas panel - Central venous blood

165

819

2.06

16.43

3.8

4.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

221

1217

1.87

16.27

2.4

3.6

93.43

73.38

u/ml

0.42

213

1169

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

24.56

15.98

1.6

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

100

408

2.49

15.91

1.9

2.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

291

1754

1.71

15.79

4.0

3.5

25.07

25.19

mmol/l

0.25

285

1699

(3019060) Gas panel - Arterial blood

385

2500

1.60

15.62

7.7

4.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1785

15234

1.32

15.59

5.7

5.1

0.00

estimate

0.50

444

2887

(3002173) Hemoglobin [Mass/volume] in Arterial blood

508

3519

1.51

15.44

10.2

7.8

112.31

121.17

g/l

17.63

492

3421

(3009261) Glucose [Presence] in Urine by Test strip

1802

15432

1.32

15.22

4.4

3.9

0.01

0.00

estimate

0.22

427

2785

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

151

3.48

15.21

1.3

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

13.08

15.15

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

157

3.41

15.04

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

532

3743

1.49

14.97

1.3

709.67

514.81

titre

1.09

120

802

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

189

3.15

14.78

1.3

1.1

69.21

40.56

mg/l

1.91

153

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

510

3585

1.49

14.38

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

397

2647

1.56

14.34

4.8

4.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

123

576

2.17

14.28

1.7

1.4

10.35

9.77

u/l

0.20

106

466

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

282

2.69

14.12

1.3

1.1

—

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.85

13.98

1.3

1.1

—

(3015736) pH of Urine

1453

12190

1.31

13.81

3.9

3.5

5.61

5.78

0.60

619

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

184

3.07

13.48

1.2

1.0

404.44

297.72

mg/l

1.07

155

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

197

1112

1.81

13.43

1.6

1.5

400.63

264.14

titre

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

4.03

13.07

1.9

1.5

1.43

6.18

ug/l

0.91

(3012501) Base excess in Blood by calculation

154

812

1.93

12.99

4.2

4.9

2.76

2.69

mmol/l

0.12

118

567

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

243

2.75

12.96

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

28.45

12.95

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

142

730

1.98

12.89

3.1

2.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.61

12.88

1.3

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2814

25899

1.33

12.81

41.5

19.2

15.44

15.25

1.23

2798

25408

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

321

2.49

12.75

1.2

1.1

—

(3035880) pH of Pleural fluid

229

2.78

12.69

1.4

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.48

12.58

13.0

3.1

44.93

40.52

umol/l

0.39

(21491868) Cryoglobulin [Mass/volume] in Serum

116

3.56

12.52

1.9

1.2

1.46

0.10

g/l

—

(3013862) HLA-DP [Type]

20.09

12.44

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

146

3.25

12.43

31.5

27.0

107.13

118.12

ug/l

0.59

122

(3026389) Candida sp identified in Specimen by Organism specific culture

383

2.33

12.23

1.4

—

(3047189) Immunofixation for 24 hour Urine

185

2.95

12.12

1.6

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.41

12.10

2.3

6.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1826

15969

1.27

11.98

2.9

2.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

348

2345

1.53

11.95

10.6

6.8

24.81

24.52

mmol/l

0.66

328

2234

(3052592) Norovirus Ag [Presence] in Stool

4.42

11.89

1.7

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

259

1632

1.63

11.86

4.5

4.0

49.70

48.56

0.32

259

1612

(3013512) EKG study

1214

10101

1.30

11.80

5.0

4.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

138

726

1.93

11.75

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

3.95

11.72

1.5

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.35

11.68

1.2

4.85

1.57

mmol/l

0.90

(3023323) Follitropin [Units/volume] in Serum or Plasma

114

562

2.06

11.65

1.6

1.4

28.42

30.35

iu/l

0.23

471

(40763590) HLA-DQ beta [Type]

18.97

11.57

1.0

—

(46236302) HLA-C [Type] by High resolution typing

18.97

11.57

1.0

—

(40760409) HLA-A [Type] by High resolution

18.97

11.57

1.0

—

(40760410) HLA-B [Type] by High resolution

18.97

11.57

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

11.46

1.0

0.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

139

3.19

11.35

1.9

1.5

2.01

2.88

0.32

120

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

172

2.93

11.17

1.2

1.0

—

(3017704) Immunofixation for Urine

205

2.76

11.17

1.4

1.6

—

(3010421) pH of Blood

168

958

1.79

11.11

4.3

4.7

7.43

7.42

2.05

154

865

(3019309) Folate [Moles/volume] in Red Blood Cells

856

6844

1.32

11.03

1.8

1207.24

1170.33

nmol/l

0.52

683

5099

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.02

10.98

1.7

1.2

76.61

112.55

ng/l

0.26

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

163

2.97

10.98

1.9

1.4

67.90

67.62

0.02

133

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

2.97

10.98

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

501

2.09

10.93

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

107

530

2.05

10.82

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

301

2014

1.54

10.67

13.3

9.6

—

(3052851) Hemolysis interference index of Serum or Plasma

174

1015

1.75

10.66

3.8

3.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.24

10.54

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1233

10395

1.27

10.53

2.2

162.75

216.05

u/l

2.01

1170

9711

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

146

3.04

10.48

1.2

1.1

1.17

1.18

u/l

0.01

(40768443) Skin Pathology biopsy report

228

1438

1.62

10.42

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

131

3.15

10.41

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.71

10.36

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.71

10.36

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.71

10.36

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

386

2.20

10.32

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

123

3.19

10.12

29.8

31.7

7.04

7.37

ug/l

0.38

107

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

142

794

1.82

10.05

2.0

3.4

681.13

745.09

u/ml

0.03

126

727

(3010838) Calcium [Moles/time] in 24 hour Urine

107

546

1.99

10.00

1.8

1.9

5.40

4.77

mmol/24h

0.89

467

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.62

9.99

1.2

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

370

2622

1.46

9.90

3.8

4.0

89.12

96.67

ng/l

0.77

316

2245

(40767503) Oxygen content in Capillary blood by calculation

142

802

1.80

9.74

3.3

2.5

14.61

16.12

4.87

420

(3044889) 12 lead EKG panel

2452

22483

1.25

9.70

5.0

4.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3080

29033

1.31

9.70

32.6

15.4

76.67

76.12

ml/min/173m2

0.76

2798

24092

(3029937) Albumin [Presence] in Urine by Test strip

1009

8376

1.28

9.60

5.0

4.2

0.01

0.00

estimate

0.31

414

2739

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

315

2.28

9.52

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

15.05

9.50

1.5

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

254

2.42

9.44

1.1

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

244

1602

1.56

9.43

2.6

3.3

4.23

4.41

pmol/l

2.66

220

1388

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

121

661

1.86

9.26

1.2

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.55

9.21

1.1

950.63

1625.78

miu/ml

3.05

(40761995) Spermatozoa Progressive [#/volume] in Semen

7.73

9.11

1.7

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

7.73

9.11

3.5

6.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

142

2.91

9.11

1.5

5.7

70.34

64.81

mg/l

0.11

100

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

142

2.91

9.11

1.6

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.09

8.97

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

146

858

1.73

8.77

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

147

867

1.72

8.72

1.4

1.2

—

(3037121) Protein [Mass/volume] in Urine

187

1176

1.62

8.69

2.8

3.1

0.70

0.29

g/l

0.86

485

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

4.25

8.65

1.3

2.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

441

3302

1.38

8.62

3.2

3.0

272.26

214.93

ng/l

1.53

409

3027

(42529406) Shigella sp [Presence] in Stool by Culture

147

872

1.71

8.55

1.4

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1594

14072

1.23

8.53

2.1

91.84

93.48

pmol/l

0.68

927

7344

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

682

8410

0.77

8.53

1.7

1.6

1.42

1.36

mmol/l

1.20

576

6964

(3020891) Body temperature

222

1461

1.55

8.51

5.9

4.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3359

32188

1.35

8.45

38.1

19.1

139.34

139.64

mmol/l

9.42

3318

31359

(3020393) Adenovirus Ag [Presence] in Stool

7.34

8.43

1.7

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2819

29792

0.80

8.36

4.3

4.7

1.35

1.43

mmol/l

17.01

2518

26999

(3006922) Hepatitis E virus Ab [Presence] in Serum

178

2.60

8.33

1.1

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

140

826

1.72

8.31

2.7

2.2

118.81

128.78

g/l

4.26

103

601

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

168

2.64

8.19

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

168

2.64

8.19

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

659

1.80

8.16

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.48

8.08

1.9

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

11.70

8.06

1.2

1.3

—

(3047181) Lactate [Moles/volume] in Blood

182

1161

1.60

8.00

11.4

6.0

1.32

mmol/l

0.00

155

1028

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

6.28

8.00

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2850

30042

0.80

7.94

4.4

4.7

4.44

4.51

mmol/l

2.60

2575

27437

(3022145) Colonoscopy Study observation

463

3541

1.35

7.90

1.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2730

28890

0.81

7.75

5.9

6.3

40.43

40.64

mmol/mol

0.43

2465

26422

(40765089) Chromosome analysis panel - Blood by G-banded

6.36

7.70

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3358

32258

1.33

7.64

38.7

19.3

4.00

mmol/l

0.09

3313

31381

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

118

2.90

7.58

1.4

1.3

1.36

439.50

ug/l

1.22

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

294

2.16

7.56

1.1

—

2.36

—

(3046861) Legionella sp Ag [Presence] in Urine

8.85

7.53

1.1

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2932

30766

0.80

7.50

4.8

5.3

2.62

2.63

mmol/l

0.35

2618

27928

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

4.24

7.47

1.7

2.1

117.37

114.20

ng/l

0.04

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

13.37

7.38

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

13.37

7.38

1.7

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

198

1313

1.54

7.37

4.8

3.8

1.60

1.39

mmol/l

0.96

192

1293

(3024316) Viscosity of Plasma

8.36

7.31

2.8

1.5

1.70

1.53

mpas

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

876

7351

1.25

7.31

4.2

3.8

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.15

7.27

1.2

68.36

52.44

0.67

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.49

7.26

2.0

1.5

4.85

5.54

0.16

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

15.76

7.22

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

361

2704

1.37

7.03

3.3

2.7

60.04

62.40

ml/min/173m2

0.52

148

1129

(3027974) Hepatitis B virus e Ag [Presence] in Serum

10.03

7.02

1.3

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

134

825

1.65

6.85

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

126

764

1.67

6.83

2.5

2.7

32.34

35.54

umol/l

0.77

119

677

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.26

6.82

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

275

1982

1.42

6.74

9.0

9.1

24.28

24.34

mmol/l

0.11

270

1916

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

2.67

6.72

1.4

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

384

1.95

6.72

3.3

3.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

249

1768

1.44

6.63

1.3

63.42

62.01

au/ml

0.03

102

(3004716) Salmonella sp identified in Stool by Organism specific culture

180

1199

1.53

6.60

1.4

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.88

6.60

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

12.25

6.57

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

12.25

6.57

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

194

2.34

6.56

2.9

3.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.18

6.56

1.2

1.41

1.63

mmol/l

0.62

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

220

1533

1.46

6.48

9.8

5.1

1.57

1.63

0.58

201

1436

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

624

1.72

6.43

1.3

92.23

43.06

u/l

1.62

542

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3365

32468

1.30

6.39

23.7

11.1

26.82

26.19

u/l

0.75

3321

31122

(3023383) Lactate [Moles/volume] in Pleural fluid

125

2.65

6.31

1.4

3.44

3.27

mmol/l

0.10

113

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.00

6.22

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

174

2.37

6.21

1.8

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

2.77

6.20

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

339

1.96

6.20

4.2

3.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

4.12

6.08

1.1

15.94

16.28

g/l

0.07

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.59

6.05

1.3

1.0

—

(3044927) Protein electrophoresis panel - Urine

386

1.88

5.98

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

268

1966

1.39

5.95

2.4

20.85

23.17

au/ml

0.13

120

(3005322) IgE [Units/volume] in Serum or Plasma

226

1610

1.43

5.94

1.3

526.68

225.66

u/ml

1.06

195

1477

(3007930) Methemoglobin/Hemoglobin.total in Blood

214

1510

1.44

5.92

10.5

5.2

0.89

0.88

0.23

196

1416

(3039162) Centromere protein B Ab [Units/volume] in Serum

338

1.94

5.91

1.2

61.35

47.15

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

2.79

5.88

1.3

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.38

5.85

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

2.33

5.82

1.8

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

100

597

1.69

5.80

1.3

1.2

1.44

7.58

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.78

5.46

2.9

1.9

—

(3045424) Erythrocytes [Presence] in Urine

539

1.71

5.46

1.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

147

2.39

5.46

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.90

5.45

1.1

—

(40768441) Liver Pathology biopsy report

211

2.15

5.43

1.1

1.4

—

(3051651) Icteric interference index of Serum or Plasma

192

2.20

5.40

5.3

3.6

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.88

5.34

1.7

1.1

0.07

1.59

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.88

5.34

1.7

1.1

0.70

6.15

mg/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

132

863

1.55

5.33

1.6

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.92

5.29

1.7

2.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

11.27

5.29

2.2

2.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

11.27

5.29

2.2

2.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

296

1.94

5.25

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.84

5.24

1.1

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

+∞

5.21

1.0

0.0

—

(3018572) Chloride [Moles/volume] in Blood

128

836

1.55

5.20

14.7

6.9

105.24

105.16

mmol/l

0.06

111

747

(3039000) Anion gap in Blood

128

836

1.55

5.20

14.7

6.9

10.62

11.31

mmol/l

1.65

111

747

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.35

5.14

1.7

1.2

1.93

2.76

mg/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1303

11682

1.17

5.12

4.8

4.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

572

1.66

5.12

3.0

3.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

231

2.05

5.05

4.9

5.0

38.82

45.40

u/ml

0.09

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.18

5.03

1.2

1.1

—

(40758358) Immune stain study

10.02

5.02

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.41

5.02

1.4

20.73

17.62

0.12

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

111

708

1.58

5.01

1.4

1.2

1.92

3.82

u/ml

1.61

(3020876) Protein [Mass/time] in 24 hour Urine

411

1.77

4.95

2.1

2.4

0.71

1.39

g/24h

1.69

202

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

117

761

1.55

4.87

1.3

1.2

44.79

36.93

u/ml

0.16

(3002523) Influenza virus A Ag [Presence] in Specimen

298

1.89

4.83

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

163

2.22

4.77

5.7

6.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2760

28814

0.85

4.74

4.1

4.2

1.34

1.30

mmol/l

1.68

2465

25867

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

132

2.36

4.73

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

111

719

1.56

4.72

1.4

1.2

2.02

6.04

u/ml

1.78

111

(40757494) Bilirubin.total [Moles/volume] in Blood

197

2.09

4.70

2.1

2.3

14.14

24.77

umol/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

14.02

4.57

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

914

8021

1.18

4.57

4.2

3.6

—

(3036603) Volume of Urine

213

2.03

4.56

1.6

2046.79

1845.02

0.74

207

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

194

2.07

4.49

1.9

1.5

0.19

0.26

nmol/l

0.90

148

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

524

1.64

4.45

1.3

1.2

28.43

43.94

u/ml

0.52

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3349

32527

1.23

4.45

41.5

19.2

84.24

82.38

umol/l

1.75

3349

32516

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

175

1261

1.41

4.39

2.0

2.2

410.35

641.63

ug/l

0.48

164

1191

(3049717) Cytology report of Urine Cyto stain

208

1553

1.36

4.23

2.5

2.8

—

(1761868) Lipid panel - Serum or Plasma

831

9420

0.85

4.13

3.0

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

129

1837

0.69

4.12

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

412

1.69

4.11

1.2

3.18

3.96

u/ml

0.26

139

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

4.09

1.1

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.01

4.06

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

10.02

4.01

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

170

2.07

3.95

2.1

1.6

1.21

2.41

u/field

1.27

121

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2386

22628

1.14

3.92

3.9

15.04

14.97

pmol/l

0.65

2164

20255

(3028679) Herpes simplex virus Ab [Presence] in Serum

112

2.33

3.91

1.2

—

(3003181) Sodium [Moles/volume] in Urine

639

1.53

3.89

1.5

1.4

57.13

63.15

mmol/l

0.89

514

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.76

3.77

1.1

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

8.76

3.77

1.1

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.02

3.76

1.2

1.0

1.17

1.00

u/field

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

144

1033

1.41

3.76

1.4

1.2

6.69

1.04

u/ml

—

(3008295) Osmolality of Serum or Plasma

356

1.70

3.69

1.3

273.08

276.82

mosm/kgh2o

0.79

265

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.83

3.68

1.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

155

2.07

3.66

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.43

3.63

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.72

3.58

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

205

1.91

3.57

1.9

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.79

3.56

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

399

1.64

3.54

1.2

3.75

5.55

u/ml

0.79

179

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.05

3.52

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

190

1443

1.33

3.50

1.9

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

238

2994

0.78

3.37

1.4

1.5

—

(3019977) pH of Arterial blood

217

1.85

3.35

4.5

2.6

7.43

7.42

0.09

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

127

2.13

3.35

3.3

2.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

137

997

1.39

3.33

1.5

1.4

253.75

270.38

ug/g

0.43

607

(3024869) Neuronal Ab [Presence] in Serum

2.72

3.32

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.62

3.30

2.0

3.4

—

(4212803) Bone marrow aspirate examination

3.64

3.28

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

3228

31430

1.17

3.17

29.1

15.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

281

1.72

3.15

2.2

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.96

3.13

4.4

5.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

817

7304

1.15

3.11

1.7

17190315.88

26453767.04

pmol/l

0.21

669

5969

(3025130) Human papilloma virus identified in Specimen

194

1.86

3.10

2.1

1.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.18

3.05

1.7

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

113

815

1.40

2.94

3.1

0.94

0.82

nmol/l

0.82

618

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.32

2.91

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

116

2.08

2.82

1.1

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

112

816

1.38

2.76

1.2

104.29

93.28

titre

0.17

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

389

3310

1.20

2.75

2.3

2.4

7.26

7.18

ug/l

0.02

328

2899

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.71

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

2.69

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

2.66

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.80

2.64

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.22

2.63

1.3

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

456

1.50

2.62

3.1

2.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

408

1.53

2.61

6.7

23.4

7.64

7.58

mmol/l

0.05

338

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.01

2.56

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

193

1.77

2.54

1.7

1.6

8.86

6.94

u/l

0.21

160

(3035637) Corticotropin [Mass/volume] in Plasma

388

1.53

2.50

1.3

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.47

2.48

1.0

—

(3024928) Oxygen saturation in Venous blood

105

775

1.36

2.43

7.4

3.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

168

1.79

2.36

1.3

1.7

17.64

12.85

umol/l

0.15

110

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.97

2.30

6.7

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.97

2.30

6.7

2.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.95

2.28

1.5

2.3

—

(3004451) EKG impression Narrative

187

1.72

2.20

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

451

1.45

2.17

2.1

2.2

29.10

23.60

mg/l

0.38

108

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.00

2.14

2.3

4.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1172

0.74

2.14

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.10

2.12

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

482

4270

1.15

2.10

12.8

7.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1039

11174

0.90

2.09

3.9

12.28

9.29

mg/mmol

0.62

671

7141

(40761535) Cells panel - Urine sediment

333

2874

1.17

2.05

4.3

3.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

845

0.71

1.96

1.4

1.7

3.14

3.92

mg/l

0.39

621

(40759836) Histone Ab [Presence] in Serum by Immunoblot

210

1.62

1.94

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.62

1.94

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.62

1.94

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.97

1.93

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

157

1.72

1.92

1.1

104.63

92.08

u/l

0.46

142

(3047007) Chlamydophila sp Ab [Presence] in Serum

339

1.48

1.91

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

106

1.89

1.90

1.2

2.2

14363.33

20854.31

e6/l

0.13

(3039443) Prostate specific Ag panel - Serum or Plasma

640

0.67

1.90

1.6

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

100

765

1.32

1.90

4.6

3.3

7.09

7.63

mmol/l

1.65

100

743

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

192

1590

1.22

1.89

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

158

1.71

1.88

1.1

31.52

30.63

u/l

0.04

142

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

121

1.82

1.88

2.7

1.9

38.63

56.63

ug/l

1.22

116

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

189

1.65

1.87

1.0

1.1

0.13

8.03

nmol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.86

1.86

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.60

1.85

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.60

1.85

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.60

1.85

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

137

1.76

1.83

2.5

2.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

352

1.45

1.80

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.05

1.80

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.05

1.80

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

3.05

1.80

6.0

3.4

20.57

30.36

g/mol

—

(3035320) C reactive protein [Mass/volume] in Body fluid

225

1.56

1.73

2.1

2.5

—

(3017569) Oxygen content in Arterial blood

195

1.59

1.68

1.8

2.2

—

(21494755) Public health laboratory ask at order entry panel

133

1636

0.81

1.68

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

362

3201

1.14

1.66

2.3

2.2

203.96

155.33

ug/g

1.14

306

2518

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

142

1.69

1.64

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

103

813

1.27

1.59

4.5

3.2

1.57

1.63

mmol/l

0.35

103

788

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.59

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

238

1.52

1.59

1.2

—

115.00

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

388

1.40

1.57

1.2

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

294

2574

1.15

1.56

2.5

2.2

12.77

12.54

nmol/l

0.18

269

2252

(1002224) Polysomnography panel

951

0.76

1.51

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

235

1.49

1.46

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

0.48

1.46

1.3

1.2

—

(3016750) Collection duration of Urine

211

1.52

1.45

2.2

2.1

507.06

488.30

min

0.48

155

(36660697) Celiac disease serology panel - Serum

243

2111

1.16

1.45

1.1

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.88

1.44

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.88

1.44

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.88

1.44

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.88

1.44

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.73

1.43

1.0

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.97

1.43

1.7

1.8

1.79

2.09

ug/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.77

1.38

1.4

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

678

0.73

1.38

2.6

1.6

0.96

0.84

nmol/l

0.55

558

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

359

0.64

1.35

1.0

1.1

10.78

2.27

u/ml

—

199

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

383

1.36

1.35

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2839

27809

1.08

1.33

4.8

4.7

3.02

2.04

mu/l

0.50

2585

25023

(3002619) Bacteria identified in Specimen by Culture

1.97

1.32

1.6

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.50

1.30

1.0

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

106

1289

0.82

1.27

1.1

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.82

1.25

1.4

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.40

1.24

1.2

1.3

1.74

0.86

ml/s/173m2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.63

1.21

1.2

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

229

1.44

1.21

1.4

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1006

10605

0.93

1.20

3.4

3.3

1119.81

288.01

mg/l

3.10

665

6874

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

133

1.58

1.17

1.1

1.2

1.24

1.06

ratio

—

(1761482) Bacteria [#/volume] in Urine by Culture

114

950

1.21

1.15

4.7

4.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.00

1.12

1.5

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

2.26

1.10

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3390

33518

1.10

52.1

23.9

37.52

40.07

38.97

3198

31024

(3000330) Specific gravity of Urine by Test strip

204

1793

1.15

1.10

3.7

3.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.82

1.09

1.1

0.10

4.19

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.19

1.08

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

302

0.66

1.06

1.0

1.1

2.70

2.10

u/ml

—

134

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.12

1.05

1.1

1.0

0.35

10.35

u/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

162

1.48

1.04

1.3

1.2

158.21

363.49

u/l

1.79

150

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.27

1.03

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

315

1.34

1.02

1.0

1.59

2.81

u/ml

1.31

108

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

111

1310

0.84

1.01

1.4

1.7

—

(3024731) MCV [Entitic volume]

3390

33542

1.09

1.00

51.7

23.7

92.06

91.50

9.67

3358

32956

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.00

1.00

1.9

2.1

20.41

17.88

umol/l

—

(3035941) MCH [Entitic mass]

3390

33543

1.09

0.99

51.6

23.6

30.52

30.44

1.74

3358

32956

(3026361) Erythrocytes [#/volume] in Blood

3390

33545

1.09

0.99

51.9

23.7

4.17

4.46

e12/l

140.44

3316

32431

(3010813) Leukocytes [#/volume] in Blood

3390

33546

1.09

0.98

51.9

23.8

6.73

6.84

e9/l

0.84

3319

32429

(3007461) Platelets [#/volume] in Blood

3389

33536

1.09

0.98

52.0

23.8

217.05

242.74

e9/l

73.42

3322

32545

(3006442) Creatine [Moles/volume] in Serum or Plasma

223

1.39

0.98

1.6

1.7

93.16

88.69

umol/l

0.12

223

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

702

1.22

0.98

1.1

4.54

7.84

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

3390

33552

1.09

0.96

52.1

23.9

125.00

134.85

g/l

192.92

3357

32967

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

204

1819

1.13

0.92

2.4

2.5

—

(3009508) Creatinine [Moles/volume] in Urine

1046

10920

0.94

0.92

3.2

7.07

7.46

mmol/l

2.35

867

9101

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.90

1.1

1.3

79.56

82.52

—

(3011648) Oxygen content in Venous blood

288

1.32

0.89

11.8

2.9

10.30

11.10

0.52

288

(3045683) HLA typing for celiac disease panel - Blood or Tissue

127

1.50

0.88

1.0

—

(3014891) Appearance of Pleural fluid

1.79

0.87

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.00

0.87

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

493

0.77

0.86

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

212

1.37

0.86

1.4

1.5

15.57

14.35

umol/l

0.39

198

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

606

1.21

0.83

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

308

0.71

0.83

1.0

1.1

10.82

4.87

u/ml

—

156

(44816559) Phosphatidylethanol [Mass/volume] in Blood

500

0.78

0.82

1.5

1.3

—

(3044007) Cell count panel - Peritoneal fluid

1.55

0.81

1.5

2.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

150

0.60

0.78

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

286

1.30

0.78

2.5

2.0

2.06

2.13

u/field

0.03

102

(3034426) Prothrombin time (PT)

1.56

0.78

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

128

1456

0.87

0.78

1.4

1.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

31.96

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

149

1.41

0.75

1.4

1.3

5.99

6.16

mmol/l

0.29

142

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

244

1.31

0.75

1.3

1.1

75.50

56.00

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.75

0.71

5.9

4.9

42.43

54.48

ug/min

—

(4200892) Spirometry reversibility

210

2303

0.91

0.70

1.4

—

(3022621) pH of Urine by Test strip

235

2152

1.10

0.70

3.1

3.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.53

0.69

1.1

76.63

85.07

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

144

1.39

0.67

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

621

5913

1.06

0.67

1.3

1.2

2.44

1.75

u/ml

0.48

139

1495

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.63

0.66

7.6

14.3

8.84

5.52

mmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

284

3062

0.92

0.66

1.7

1.8

1.51

1.56

0.35

233

2626

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

495

0.81

0.66

1.1

2.17

57.50

iu/ml

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.79

0.66

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

861

0.86

0.64

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1102

11379

0.96

0.63

4.2

4.5

21.42

21.90

0.49

568

5882

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

129

1.40

0.63

1.1

135.44

233.68

iu/ml

1.65

129

(3051387) C reactive protein [Mass/volume] in Capillary blood

749

1.15

0.61

3.9

3.6

25.29

29.49

mg/l

0.77

474

(4146454) Self-monitoring of blood glucose

412

0.80

0.60

2.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.3

—

357.40

—

(1617658) Protocol used for examination of sentinel lymph nodes

198

0.71

0.60

1.0

—

(3033799) Differential panel - Peritoneal fluid

105

1.43

0.60

1.2

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

326

1.23

0.59

1.6

1.3

13482.03

109090.17

e6/l

1.91

226

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.54

0.59

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

363

1.21

0.58

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

202

1.29

0.57

2.5

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

264

0.76

0.57

1.5

—

(4281824) Cell count and differential, peritoneal fluid

283

1.24

0.56

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

115

1.39

0.56

3.0

2.7

26.62

30.02

umol/l

0.59

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

321

1.22

0.54

1.4

1.5

34.10

27.49

0.46

194

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.46

0.54

1.0

—

(3027944) Amphetamines [Presence] in Urine

492

0.83

0.54

1.1

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.43

0.53

1.1

3.23

1.53

u/ml

—

(3016879) Cocaine [Presence] in Urine

469

0.83

0.52

1.2

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

134

0.67

0.51

1.2

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.50

0.51

1.8

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

500

0.84

0.51

1.1

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.47

0.50

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

235

0.76

0.49

1.2

2.4

—

(3019150) Specific gravity of Urine by Refractometry

704

6791

1.04

0.49

4.9

4.3

1.02

kg/l

0.55

117

1034

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

392

1.18

0.47

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

121

0.66

0.45

3.1

1.6

—

(3004775) Volume in Urine collected for unspecified duration

302

1.19

0.44

2.5

2.2

813.70

624.12

1.08

195

(3009466) Valproate [Moles/volume] in Serum or Plasma

437

0.85

0.43

3.2

4.8

304.93

350.62

umol/l

1.18

379

(3027008) Opiates [Presence] in Urine

501

0.86

0.43

1.1

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

110

1002

1.10

0.43

1.7

1.6

—

(40768800) Prostate Pathology biopsy report

952

0.90

0.41

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.41

0.0

1.0

—

79.18

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

32.38

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.97

—

(3042733) HLA Ab [Presence] in Serum

1.36

0.40

4.1

5.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

446

1.15

0.39

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.39

1.8

2.4

0.40

0.54

u/field

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

1.27

0.38

1.1

—

(3024263) Appearance of Synovial fluid

203

0.79

0.37

1.3

1.4

—

(3001729) Color of Synovial fluid

1.35

0.37

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

503

0.87

0.36

1.1

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

888

1.09

0.36

2.6

2.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.27

0.36

7.3

7.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

491

4740

1.04

0.35

1.2

1.3

50.13

36.95

iu/ml

0.74

156

1490

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

157

0.76

0.35

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

470

0.87

0.35

1.2

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

122

0.74

0.35

1.3

79.56

163.15

mmol/24h

—

122

(3008898) HLA-B27 [Presence]

737

1.10

0.35

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.37

0.34

1.1

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

200

0.80

0.34

1.3

6.75

1.25

u/ml

—

115

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

329

0.85

0.33

1.3

1.32

1.50

nmol/l

0.53

294

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

166

1561

1.07

0.33

1.2

135.06

139.22

iu/ml

0.04

550

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

144

0.76

0.33

1.6

1.4

1.52

1.54

g/l

0.12

144

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.70

0.33

2.8

2.3

130.17

139.49

nmol/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

426

1.13

0.32

1.0

1.1

1.69

1.55

g/l

1.51

377

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.28

0.32

1.2

1.3

11.08

207899.94

nmol/l

—

(40768793) Breast Pathology biopsy report

589

1.11

0.31

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

548

0.89

0.31

1.5

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

212

1.18

0.30

2.0

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

1970

0.95

0.29

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.25

0.29

1.0

1.1

—

78.11

—

(3006270) Folate [Moles/volume] in Blood

289

1.14

0.28

1.1

1.2

326.61

345.71

nmol/l

0.18

238

(3050129) First trimester maternal screen panel - Serum or Plasma

172

0.81

0.27

1.5

—

(3006462) Nitrate [Presence] in Urine

159

1.20

0.26

2.9

3.9

—

(3036180) Methadone [Presence] in Urine

0.67

0.25

1.0

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.28

0.24

1.3

—

(3021788) Differential panel - Synovial fluid

619

1.08

0.24

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

265

0.87

0.24

1.0

754.94

698.11

ng/l

0.21

170

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

264

0.87

0.23

1.0

48.76

44.39

ng/l

0.24

172

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.28

0.23

1.0

1.2

2.14

1.88

umol/24h

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.74

0.22

1.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

389

0.90

0.22

1.2

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

263

0.87

0.22

1.0

337.89

314.55

ng/l

0.21

175

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.22

0.22

2.0

2.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

167

0.84

0.21

1.6

1.3

1.43

1.17

nmol/l

—

128

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

1.96

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

11.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.75

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

8.09

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.84

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

429

0.91

0.21

1.3

0.69

0.66

nmol/l

0.11

406

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.25

0.20

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

229

0.87

0.20

1.0

1.1

15.35

2.57

u/ml

—

110

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

288

1.11

0.20

1.2

1.6

39.20

22.71

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.22

0.19

2.4

1.4

10.58

9.11

ug/l

0.20

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.24

0.18

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.24

0.18

1.1

1.0

—

(3000492) Spirometry study

286

2779

1.03

0.18

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate

109

1.19

0.18

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

909

0.94

0.18

2.4

2.2

180.16

104.57

ug/min

0.47

549

(4094501) Cardiovascular stress test using bicycle ergometer

888

0.94

0.18

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

824

1.06

0.18

1.9

1.6

17261.30

13611.44

e6/l

0.25

597

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.14

0.16

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

235

0.89

0.16

1.2

2.0

8.43

6.77

mmol/l

0.96

157

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

111

1.17

0.15

1.2

2.1

247.42

92.02

ug/l

0.28

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.77

0.15

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

770

1.05

0.15

1.5

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

388

0.93

0.14

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

421

1.07

0.14

1.5

62.31

60.99

0.08

262

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

199

1.11

0.13

1.4

1.6

—

(4034850) Laboratory test

1009

0.96

0.13

12.5

10.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

123

1.14

0.12

1.2

2.3

108.11

111.99

umol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

411

4178

0.98

0.12

4.3

4.8

31.50

32.87

1.62

290

2755

(3011288) Drugs identified in Urine by Screen method

328

1.07

0.11

1.1

2.6

—

(44813793) Dust mix specific IgE antibody measurement

167

0.90

0.10

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

300

3049

0.98

0.09

1.5

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

207

0.92

0.09

1.0

1.1

2.27

4.30

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

145

1.10

0.09

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.11

0.09

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.11

0.09

1.0

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.09

0.08

1.0

1.1

—

77.06

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.09

0.08

2.5

2.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.03

0.08

2.2

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

807

8129

0.99

0.08

2.9

3.2

0.77

0.79

ug/l

0.32

566

5703

(37021550) Renin [Units/volume] in Plasma --upright

0.83

0.07

1.3

78.73

63.88

mu/l

—

(3020650) Glucose [Presence] in Urine

0.87

0.07

1.0

1.5

—

(3025577) Chromium [Mass/volume] in Blood

245

0.94

0.07

2.3

2.1

1.94

1.95

ug/l

0.01

206

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.05

0.07

7.3

7.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

206

1.07

0.07

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

234

0.94

0.06

1.3

1.4

1.39

1.20

promille

0.23

182

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.06

6.5

7.3

—

(3000034) Microalbumin [Mass/volume] in Urine

335

1.05

0.06

3.6

3.1

23.52

28.96

mg/l

0.21

265

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

192

0.94

0.05

1.9

1.6

0.92

0.96

g/l

0.34

192

(3011985) Renin [Units/volume] in Plasma

415

1.04

0.05

1.3

1.4

45.99

63.04

mu/l

0.44

367

(3023511) Choriogonadotropin [Units/volume] in Urine

139

1.08

0.05

1.0

1.3

—

(3003338) MCHC [Mass/volume]

2486

24812

1.01

0.05

45.1

21.2

331.21

332.18

g/l

5.71

2466

24599

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

595

0.97

0.04

1.2

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

635

1.02

0.04

1.9

1.8

11.26

4.98

iu/l

1.11

200

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

936

0.98

0.04

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

382

0.97

0.04

1.2

1.4

260.45

300.84

pmol/l

0.58

329

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3000

30027

1.00

0.03

5.0

5.99

6.07

mmol/l

2.44

2711

26955

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

380

0.97

0.02

1.3

—

nmol/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

0.95

0.02

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

0.95

0.02

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

162

1.05

0.02

1.4

1.2

109.35

140.53

nmol/l

3.70

162

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.08

0.02

2.3

1.9

1.30

1.32

ug/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

117

0.94

0.01

1.2

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1419

14172

1.00

0.01

4.8

5.3

2.86

3.79

ug/l

1.14

1249

12660

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

147

0.95

0.01

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

147

0.95

0.01

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

126

0.95

0.00

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

186

0.97

0.00

9.2

13.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.05

0.00

1.3

2.4

272.40

191.71

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

125

0.96

0.00

1.7

1.8

1.74

9.04

nmol/l

1.26

107

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

205

1.02

0.00

1.6

1.4

134.62

203.52

pmol/l

0.79

205

(3047352) Trisomy 18 risk [Likelihood] in Fetus

124

0.97

0.00

1.2

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

449

4493

1.00

0.00

1.2

13.67

14.39

u/ml

0.07

153

1628

(3005033) Fetal Nuchal fold Thickness US

123

0.98

0.00

1.2

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.91

0.00

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1740.00

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3776.00

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

6.3

—

50.88

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.98

-0.00

2.2

1.5

14.78

15.10

pmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3022689) Creatine [Moles/volume] in Urine

0.98

-0.00

2.1

1.5

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

30.62

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.40

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

433.67

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

36.50

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.98

-0.00

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

160

1.00

-0.00

1.4

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-follicular lymphoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-follicular lymphoma (CD2_NONFOLLICULAR_LYMPHOMA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints